
Citiverlin P 500mg/800mg Tablet
Marketer
Gopal Lifesciences
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citiverlin P 500mg/800mg Tablet
Neuro-Mend 500mg/800mg tablets aid in stroke recovery and cognitive function improvement. This medication safeguards brain cells from injury and facilitates their repair, also finding application in brain injury treatment. Neuro-Mend 500mg/800mg tablets can be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's dosage and duration instructions; if a dose is missed, take it immediately upon recollection. Complete the prescribed course, even with symptom improvement; abruptly ceasing treatment without consulting your doctor may worsen your condition. Potential side effects, such as restlessness, abdominal discomfort, anxiety, and lowered blood pressure, are usually transient and self-limiting. Consult your doctor if these persist or are bothersome. Maintain adequate hydration due to potential diarrhea. Weight gain is possible; manage this through balanced nutrition and regular exercise.
Uses of Citiverlin P 500mg/800mg Tablet
Stroke Recovery Program
Major Benefits of Citiverlin P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Citiverlin P 500mg/800mg tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Citiverlin P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citiverlin P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Citiverlin P 500mg/800mg Tablet whole; avoid chewing, crushing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Citiverlin P 500mg/800mg Tablet works:
Citiverlin P 500mg/800mg tablets contain citicoline and piracetam, two agents that synergistically support neurological health. Citicoline acts as a neuroprotectant, fostering neuronal survival by nourishing and shielding nerve cells from injury. Piracetam, a GABA analogue, offers neuroprotection against oxygen deprivation and modulates ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Citiverlin P 500mg/800mg tablets lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citiverlin P 500mg/800mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Citiverlin P 500mg/800mg Tablet while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Citiverlin P 500mg/800mg Tablets, which can induce drowsiness and tremor. These side effects could negatively impact your ability to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Citiverlin P 500mg/800mg tablets, potentially requiring dosage modification. Medical advice is recommended. Citiverlin P 500mg/800mg tablets are contraindicated in individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Citiverlin P 500mg/800mg tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Citiverlin P 500mg/800mg Tablet :
Should you forget a dose of Citiverlin P 500mg/800mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Citiverlin P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
